Successful molecular targeted treatment of AML in pregnancy with Azacitidine and Sorafenib with no adverse fetal outcomes

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|180|4|603-604

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.180, Iss.4, 2018-02, pp. : 603-604

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Complicated multiple pregnancy referral, treatment and outcomes at the NSW Fetal Therapy Centre

By  

Australasian Journal of Ultrasound in Medicine, Vol. 17, Iss. 3, 2014-08 ,pp. : 120-124

John Wiley & Sons Inc

Access to resources Recommend Favorite

Positioning of a Molecular-Targeted Agent, Sorafenib, in the Treatment Algorithm for Hepatocellular Carcinoma and Implication of Many Complete Remission Cases in Japan

By  

Oncology, Vol. 78, Iss. 1, 2010-07 ,pp. : 154-166

Karger

Access to resources Recommend Favorite

Adverse pregnancy outcomes associated with adenomyosis with uterine enlargement

By  

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 41, Iss. 4, 2015-04 ,pp. : 529-533

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparative outcomes of everolimus, temsirolimus and sorafenib as second targeted therapies for metastatic renal cell carcinoma: a US medical record review

By Wong Michael K.   Yang Hongbo   Signorovitch James E.   Wang Xufang   Liu Zhimei   Liu Nathan S.   Qi Cynthia Z.   George Daniel J.  

Current Medical Research and Opinion, Vol. 30, Iss. 4, 2014-04 ,pp. : 537-545

Informa Healthcare

Access to resources Recommend Favorite

A Successful Treatment of Cervical Ectopic Pregnancy with Multidose Methotrexate

By  

Current Women's Health Reviews, Vol. 12, Iss. 1, 2016-08 ,pp. : 71-73

Bentham Science Publishers

Access to resources Recommend Favorite